Oxford Asset Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-29,657	Closed	-$3.21M	–	1610
2019 Q4	$3.21M	Sell	29,657 -7,349	-20%	-$786K	0.09%	231
2019 Q3	$3.62M	Sell	37,006 -54,158	-59%	-$6.1M	0.09%	270
2019 Q2	$11.9M	Buy	+91,164	New	+$11.7M	0.26%	57
2019 Q1	–	Sell	-14,660	Closed	-$1.43M	–	2123
2018 Q4	$1.43M	Buy	+14,660	New	+$1.73M	0.04%	671
2018 Q3	–	Sell	-42,588	Closed	-$5.28M	–	2036
2018 Q2	$5.28M	Buy	42,588 +34,621	+435%	+$4.05M	0.1%	221
2018 Q1	$888K	Buy	+7,967	New	+$952K	0.02%	991
2017 Q4	–	Sell	-36,710	Closed	-$5.15M	–	1941
2017 Q3	$5.15M	Sell	36,710 -65,518	-64%	-$8.9M	0.1%	220
2017 Q2	$12.4M	Buy	+102,228	New	+$11.9M	0.25%	41
2015 Q1	–	Sell	-15,495	Closed	-$2.91M	–	783
2014 Q4	$2.91M	Buy	+15,495	New	+$2.87M	0.06%	297
2013 Q3	–	Sell	-8,772	Closed	-$809K	–	946
2013 Q2	$809K	Buy	+8,772	New	+$845K	0.02%	622